The risk of long COVID was two to three times higher after the initial infection (14.8%) than after first (5.8%) or second (5.3%) reinfections.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The B117 variant accounted for most viruses in one Minnesota sampling.
Researchers describe infection rates in a real-world scenario amid a surge of infections.
Until COVID, TB was the world's top infectious cause of death, and the pandemic threatens to derail efforts to curtail it.
Remdesivir treatment of hospitalized patients with noncritical COVID-19 is associated with better clinical improvement, shorter recovery and hospital stays, and safety, according to a meta-analysis of five randomized clinical trials published today in the Journal of Antimicrobial Chemotherapy. No significant association was found in regards to mortality.
"Interdisciplinary cooperation is needed for comprehensive care of these patients."
Parts of Peru and Paraguay are also reporting pressure on ICUs, with Venezuela and Uruguay reporting surges.
The NIAID says the company may have included outdated data from a clinical trial.
People with COVID-19 infections who also used the inflammatory bowel disease (IBD) drug infliximab had significantly fewer detectable antibodies than those who used vedolizumab, which treats IBD without the immune suppression, according to a study yesterday in Gut.
"We can look at the surge that happened in Europe, and we do not want that to happen."
"The inequitable distribution of vaccines is not just a moral outrage. It's also economically and epidemiologically self-defeating."
